Trulicity 0.75 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F7MAG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $0
Award facts
- Contract value 0% obligated
-
- $0.00 Current, with exercised options
- $2,907.40 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,907.40 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens (0.5 mL) on November 17, 2025, with completion scheduled for November 18, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office, with performance to occur at the company's Conshohocken, Pennsylvania location. The award is a child contract under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
This delivery order exemplifies the routine pharmaceutical procurement activities conducted through the SPE2DX global pharmaceutical support vehicle, which enables AmerisourceBergen to supply critical medical commodities across multiple therapeutic domains to support military healthcare programs worldwide. Trulicity, a diabetes management medication, represents the type of specialty pharmaceutical products regularly distributed through this comprehensive contract vehicle to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The small individual order value reflects the transactional nature of delivery orders issued against the broader IDC framework, which provides the DLA with flexible procurement capacity for medical supplies essential to military operations and personnel healthcare.
Quick answers
Who was awarded contract SPE2DR26F7MAG?
SPE2DR26F7MAG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26F7MAG worth?
The government has obligated $0 on SPE2DR26F7MAG. Its potential value, with all options, is $2,907.
Is contract SPE2DR26F7MAG an order under another contract?
Yes. SPE2DR26F7MAG is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7MAG competed?
The extent of competition for SPE2DR26F7MAG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award